---
figid: PMC7711884__jpm-10-00237-g001
figlink: pmc/articles/PMC7711884/figure/jpm-10-00237-f001/
number: F1
caption: Graphic scheme of the genes involved in the adsorption, distribution, metabolism
  and excretion (ADME) of fluoropyrimidines []. Capecitabine passes through the gut
  wall and is metabolised into 5-deoxyfluorocytidine (5′dFCR) and 5’-deoxy-5-fluorouridine
  (5′dFUR) by carboxyl esterases (CES) and cytidine deaminase (CDA), respectively,
  and activated into 5-FU by thymidine phosphorylase (TP). - 5-FU is metabolised mostly
  in the liver by dihydropyrimidine dehydrogenase (DPD) (<80%) into dihydrofluorouracil
  (DHFU). The secondary elimination pathway is through urinary excretion or catabolism
  in extrahepatic tissues []. Its mechanism of action involves the methylenetetrahydrofolate
  reductase (MTHFR)—converting 5,10-methylentetrahydrofolate (5,10-MTHF) into 5-MTHF,
  which is required for purine and thymidine synthesis, and thymidylate synthase (TS)
  enzymes—forming a complex with 5,10-MTHF and deoxyuridine monophosphate (dUMP),
  which in the end disrupts DNA replication and repair. Used with PharmGKB and Stanford
  University permission (available at https://www.pharmgkb.org/pathway/PA150653776
  (accessed on 24 September 2020)).
pmcid: PMC7711884
papertitle: 'The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer
  to Individualised Treatment?.'
reftext: Ana Rita Simões, et al. J Pers Med. 2020 Dec;10(4):237.
pmc_ranked_result_index: '42704'
pathway_score: 0.9532319
filename: jpm-10-00237-g001.jpg
figtitle: 'Graphic scheme of the genes involved in the adsorption, distribution, metabolism
  and excretion (ADME) of fluoropyrimidines '
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7711884__jpm-10-00237-g001.html
  '@type': Dataset
  description: Graphic scheme of the genes involved in the adsorption, distribution,
    metabolism and excretion (ADME) of fluoropyrimidines []. Capecitabine passes through
    the gut wall and is metabolised into 5-deoxyfluorocytidine (5′dFCR) and 5’-deoxy-5-fluorouridine
    (5′dFUR) by carboxyl esterases (CES) and cytidine deaminase (CDA), respectively,
    and activated into 5-FU by thymidine phosphorylase (TP). - 5-FU is metabolised
    mostly in the liver by dihydropyrimidine dehydrogenase (DPD) (<80%) into dihydrofluorouracil
    (DHFU). The secondary elimination pathway is through urinary excretion or catabolism
    in extrahepatic tissues []. Its mechanism of action involves the methylenetetrahydrofolate
    reductase (MTHFR)—converting 5,10-methylentetrahydrofolate (5,10-MTHF) into 5-MTHF,
    which is required for purine and thymidine synthesis, and thymidylate synthase
    (TS) enzymes—forming a complex with 5,10-MTHF and deoxyuridine monophosphate (dUMP),
    which in the end disrupts DNA replication and repair. Used with PharmGKB and Stanford
    University permission (available at https://www.pharmgkb.org/pathway/PA150653776
    (accessed on 24 September 2020)).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC22A7
  - ABCG2
  - CES1
  - CES2
  - CDA
  - CYP2A6
  - UPP1
  - TYMP
  - EMP1
  - UPP2
  - UPB1
  - DPYD
  - DPYS
  - UMPS
  - PPAT
  - TK1
  - UCK1
  - UCK2
  - RRM1
  - RRM2
  - TYMS
  - SLC29A1
  - ABCC5
  - ABCC4
  - ABCC3
  - Fluorouracil
  - Capecitabine
  - 5'-Hydroxytegafur
  - DHFU
  - Floxuridine
  - Fluorouridine
  - FdUMP
  - FUDP
  - FdUDP
  - FdUTP
  - Fluoropyrimidines
  - PD
genes:
- word: SLC22A7
  symbol: SLC22A7
  source: hgnc_symbol
  hgnc_symbol: SLC22A7
  entrez: '10864'
- word: ABCG2
  symbol: ABCG2
  source: hgnc_symbol
  hgnc_symbol: ABCG2
  entrez: '9429'
- word: CES1
  symbol: CES1
  source: hgnc_symbol
  hgnc_symbol: CES1
  entrez: '1066'
- word: CES2
  symbol: CES2
  source: hgnc_symbol
  hgnc_symbol: CES2
  entrez: '8824'
- word: CDA
  symbol: CDA
  source: hgnc_symbol
  hgnc_symbol: CDA
  entrez: '978'
- word: CYP2A6
  symbol: CYP2A6
  source: hgnc_symbol
  hgnc_symbol: CYP2A6
  entrez: '1548'
- word: UPP1
  symbol: UPP1
  source: hgnc_symbol
  hgnc_symbol: UPP1
  entrez: '7378'
- word: ΤΥMP
  symbol: TYMP
  source: hgnc_symbol
  hgnc_symbol: TYMP
  entrez: '1890'
- word: ΤΥMP
  symbol: TMP
  source: hgnc_alias_symbol
  hgnc_symbol: EMP1
  entrez: '2012'
- word: UPP2
  symbol: UPP2
  source: hgnc_symbol
  hgnc_symbol: UPP2
  entrez: '151531'
- word: UPB1
  symbol: UPB1
  source: hgnc_symbol
  hgnc_symbol: UPB1
  entrez: '51733'
- word: TYMP
  symbol: TYMP
  source: hgnc_symbol
  hgnc_symbol: TYMP
  entrez: '1890'
- word: DPYD
  symbol: DPYD
  source: hgnc_symbol
  hgnc_symbol: DPYD
  entrez: '1806'
- word: DPYS
  symbol: DPYS
  source: hgnc_symbol
  hgnc_symbol: DPYS
  entrez: '1807'
- word: UMPS
  symbol: UMPS
  source: hgnc_symbol
  hgnc_symbol: UMPS
  entrez: '7372'
- word: UPP1
  symbol: UPP1
  source: hgnc_symbol
  hgnc_symbol: UPP1
  entrez: '7378'
- word: PPAT
  symbol: PPAT
  source: hgnc_symbol
  hgnc_symbol: PPAT
  entrez: '5471'
- word: UPP2
  symbol: UPP2
  source: hgnc_symbol
  hgnc_symbol: UPP2
  entrez: '151531'
- word: TK1
  symbol: TK1
  source: hgnc_symbol
  hgnc_symbol: TK1
  entrez: '7083'
- word: UCK1
  symbol: UCK1
  source: hgnc_symbol
  hgnc_symbol: UCK1
  entrez: '83549'
- word: UCK2
  symbol: UCK2
  source: hgnc_symbol
  hgnc_symbol: UCK2
  entrez: '7371'
- word: RRM1
  symbol: RRM1
  source: hgnc_symbol
  hgnc_symbol: RRM1
  entrez: '6240'
- word: RRM2
  symbol: RRM2
  source: hgnc_symbol
  hgnc_symbol: RRM2
  entrez: '6241'
- word: TYMS
  symbol: TYMS
  source: hgnc_symbol
  hgnc_symbol: TYMS
  entrez: '7298'
- word: SLC29A1
  symbol: SLC29A1
  source: hgnc_symbol
  hgnc_symbol: SLC29A1
  entrez: '2030'
- word: ABCC5
  symbol: ABCC5
  source: hgnc_symbol
  hgnc_symbol: ABCC5
  entrez: '10057'
- word: ABCC4
  symbol: ABCC4
  source: hgnc_symbol
  hgnc_symbol: ABCC4
  entrez: '10257'
- word: ABCC3
  symbol: ABCC3
  source: hgnc_symbol
  hgnc_symbol: ABCC3
  entrez: '8714'
chemicals:
- word: Fluorouracil
  source: MESH
  identifier: D005472
- word: Capecitabine
  source: MESH
  identifier: C110904
- word: 5'-Hydroxytegafur
  source: MESH
  identifier: C068492
- word: DHFU
  source: MESH
  identifier: C019389
- word: Floxuridine
  source: MESH
  identifier: D005467
- word: Fluorouridine
  source: MESH
  identifier: C001943
- word: FdUMP
  source: MESH
  identifier: D005468
- word: FUDP
  source: MESH
  identifier: C091842
- word: FdUDP
  source: MESH
  identifier: C092815
- word: FdUTP
  source: MESH
  identifier: C105691
- word: Fluoropyrimidines
  source: MESH
  identifier: C029269
diseases:
- word: PD
  source: MESH
  identifier: D010300
figid_alias: PMC7711884__F1
redirect_from: /figures/PMC7711884__F1
figtype: Figure
---
